IDEXX LABORATORIES INC /DE Effective Income Tax Rate Reconciliation, Deduction, Dividend, Percent
IDEXX LABORATORIES INC /DE (IDXX) reported Effective Income Tax Rate Reconciliation, Deduction, Dividend, Percent of 4.00% for the 3-month period ending 2017-09-30, per its 10-Q filed 2017-10-31.
Discontinued › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationDeductionsDividends · last filed 2017-10-31
- IDEXX LABORATORIES INC /DE effective income tax rate reconciliation, deduction, dividend, percent for the quarter ending 2017-09-30 was 4.00%.
- IDEXX LABORATORIES INC /DE effective income tax rate reconciliation, deduction, dividend, percent for the quarter ending 2017-06-30 was 6.00%.
- IDEXX LABORATORIES INC /DE effective income tax rate reconciliation, deduction, dividend, percent for the quarter ending 2017-03-31 was 13.00%.
| Period end | Effective Income Tax Rate Reconciliation, Deduction, Dividend, Percent 3 month | Effective Income Tax Rate Reconciliation, Deduction, Dividend, Percent 6 month | Effective Income Tax Rate Reconciliation, Deduction, Dividend, Percent 9 month |
|---|---|---|---|
| 2017-09-30 | 4.00% 10-Q · filed 2017-10-31 | 8.00% 10-Q · filed 2017-10-31 | |
| 2017-06-30 | 6.00% 10-Q · filed 2017-08-01 | 9.00% 10-Q · filed 2017-08-01 | |
| 2017-03-31 | 13.00% 10-Q · filed 2017-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |